Press "Enter" to skip to content

Posts tagged as “UroToday”

No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study. – UroToday

admin 0

No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study.  UroToday Preoperative chemotherapy is underused in conjunction with…

AUA 2019: Pivotal Trial of MRI-guided Transurethral Ultrasound Ablation in Men with Localized Prostate Cancer – UroToday

admin 0

AUA 2019: Pivotal Trial of MRI-guided Transurethral Ultrasound Ablation in Men with Localized Prostate Cancer  UroToday AUA 2019 TACT study – MRI-Guided Transurethral Ultrasound Ablation (TULSA) in Patients with Localized Prostate…

AUA 2019: Phase II Trial of Estrogen Receptor Targeted Treatment of Non-Muscle Invasive Bladder Cancer with Tamoxifen – UroToday

admin 0

AUA 2019: Phase II Trial of Estrogen Receptor Targeted Treatment of Non-Muscle Invasive Bladder Cancer with Tamoxifen  UroToday AUA 2019 targeting the estrogen receptor (ER) with selective ER modulators (SERMs) for…

AUA 2019: 68Ga-PSMA-11 PET/CT Detects Prostate Cancer at Early Biochemical Recurrence with Superior Detection Rate and Reader Agreement – UroToday

admin 0

AUA 2019: 68Ga-PSMA-11 PET/CT Detects Prostate Cancer at Early Biochemical Recurrence with Superior Detection Rate and Reader Agreement  UroToday AUA 2019 18F-fluciclovine (FACBC) and 68Ga-PSMA-11 (PSMA) PET/CT scans in the setting…

AUA 2019: 18-Year Prostate Cancer-Specific Mortality after Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer – UroToday

admin 0

AUA 2019: 18-Year Prostate Cancer-Specific Mortality after Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer  UroToday AUA 2019 18-year prostate cancer specific mortality findings, improved…

AUA 2019: Rationale for Post-Ureteroscopy Intravesical Chemotherapy for Upper Tract Urothelial Carcinoma – UroToday

admin 0

AUA 2019: Rationale for Post-Ureteroscopy Intravesical Chemotherapy for Upper Tract Urothelial Carcinoma  UroToday AUA 2019 instillation of intravesical chemotherapy following ureteroscopy, the rationale for upper tract endoscopy with ureteroscopy in the…

AUA 2019: A 30-Gene Hereditary Cancer Mutation Analysis Predicts Time to Biochemical Recurrence in Clinically Localized Prostate Cancer – UroToday

admin 0

AUA 2019: A 30-Gene Hereditary Cancer Mutation Analysis Predicts Time to Biochemical Recurrence in Clinically Localized Prostate Cancer  UroToday AUA 2019 heritable mutations and family history in prostate cancer, inherited mutations…

Poorly controlled diabetes increases the risk of metastases and castration-resistant prostate cancer in men undergoing radical prostatectomy: Results from the SEARCH database. – UroToday

admin 0

Poorly controlled diabetes increases the risk of metastases and castration-resistant prostate cancer in men undergoing radical prostatectomy: Results from the SEARCH database.  UroToday Although diabetes is inversely related to prostate cancer…

Prevalence, Predictors, and Implications for Appropriate Use of Active Surveillance Management Among Black Men Diagnosed With Low-risk Prostate Cancer. – UroToday

admin 0

Prevalence, Predictors, and Implications for Appropriate Use of Active Surveillance Management Among Black Men Diagnosed With Low-risk Prostate Cancer.  UroToday Consensus guidelines recommend that active surveillance (AS) be considered in the…